News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘StemCellTransplant’ clear

  • Researchers report promising outcomes from a clinical trial with patients with a rare form of bone marrow failure who received a hematopoietic stem cell transplant after pre-treatment with immunosuppressive drugs only. This is the first trial reporting successful transplant in dyskeratosis congenita (DC) patients without the use of any radiation or conventional cytotoxic chemotherapy beforehand.

Tags: chemotherapy, StemCellTransplant

  • In a major advance in the care of patients with leukemia and other blood disorders, physicians at Dana-Farber/Brigham and Women's Cancer Center have begun using Rapid Heme Panel, a high-tech genetic test that provides, within a matter of days, an unprecedented amount of critical information to aid the choice of treatment.

Tags: StemCellTransplant, TranslationalResearch, Leukemia

  • Dana-Farber researchers found that adding bortezomib to initial treatment for chronic graft-versus-host disease allowed significant reduction of steroid medication in some patients.

Tags: GraftVersusHost, StemCellTransplant

  • Dana-Farber researchers find adding bortezomib to standard preventive therapy for graft-versus-host-disease (GVHD) results in improved outcomes for some patients.

Tags: GraftVersusHost, StemCellTransplant

  • Dana-Farber study shows patients with MDS in the 66-to-74 age range fared as well with stem cell transplantation as did patients in the 60-to-65 age range.

Tags: StemCellTransplant

  • A common, sometimes severe viral disease in patients receiving a transplant of donated stem cells can be prevented by a new drug given shortly after transplant, according to a study led by Dana-Farber Cancer Institute and Brigham and Women's Hospital researchers.

Tags: StemCellTransplant

  • Dana-Farber Cancer Institute scientists provide the first statistically-based guidelines for determining whether stem cell transplant is appropriate for patients older than 60 with myelodysplastic syndromes (MDS)

Tags: StemCellTransplant, Leukemia

  • Almost two-thirds of children who receive stem cell transplants are readmitted to the hospital within six months, according to researchers at Dana-Farber/Children’s Hospital Cancer Center in Boston.

Tags: ChildhoodCancer, StemCellTransplant

  • Dana-Farber researchers found that an experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen of care, but that the new combination could provide an alternative that could be preferable in certain scenarios.

Tags: GraftVersusHost, StemCellTransplant, Leukemia

  • Dana-Farber researchers have developed a method for determining how ready acute myeloid leukemia cells are to die, a finding that may enable oncologists to choose more effective treatments for their patients.

Tags: BasicResearch, StemCellTransplant, Leukemia

Showing 1-10 of 20 items